Theranos Stocks Medical Advisory Board With Physicians From Prominent Hospitals
The move is looked at as a push to persuade skeptics that the troubled blood-testing startup is viable.
Theranos Expands Scientific Board; CEO Says Data Will Be Shared
Theranos Inc., the blood-testing startup facing regulatory scrutiny, added physicians from prominent hospitals to its scientific and medical advisory board in a push to help persuade skeptics that the secretive company’s technology is viable. Chief Executive Officer Elizabeth Holmes said the medical board is advising the company as it seeks to become more transparent about how its technology works. Theranos has said it can run a number of tests on just one fingerprick’s worth of blood, at a fraction of the price charged by big laboratory companies like Quest Diagnostics Inc. and Laboratory Corp. of America Holdings. (Chen, 4/7)
Theranos Says New Medical Advisers Will Help Publish Data
Saying Theranos needs to do some damage control is like suggesting Donald Trump may want to take a moment to collect his thoughts before opening his mouth to speak. After damning investigations into the high-flying company’s blood-testing technology by both The Wall Street Journal and the federal government, Theranos, once valued at $9 billion, is now struggling to regain legitimacy. Today, the company announced what appears to be an attempt at rehabilitating its reputation. (Brooks, 4/7)